EP3404041
AÐFERÐ Í MEÐFERÐ VIÐ BEINÞYNNINGU
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.4.2012EP published:
22.7.2020EP application number:
18182009.3
EP translation filed:
10.8.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
17.4.2032Expiry date:
17.4.2026Next due date:
30.4.2026
Title:
METHOD FOR TREATING OSTEOPOROSIS
Timeline
Today
18.4.2012EP application
22.7.2020EP Publication
10.8.2020Translation submitted
15.10.2020Registration published
17.4.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
SAN MARTIN, JavierAddress:
Thousand Oaks, CA 91320-1799, US
Name:
WASSERMAN, ScottAddress:
Newbury Park, CA 91320, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201161477065 PDate:
19.4.2011Country:
US
Classification
Categories:
C07K 16/22
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 10.3.2021
Expires: 17.4.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.3.2022
Expires: 17.4.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 26.3.2023
Expires: 17.4.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.4.2024
Expires: 17.4.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.4.2025
Expires: 17.4.2026
Payer: Árnason Faktor ehf.